Results 171 to 180 of about 65,372 (285)

Impact of Proteinuria on Renal Outcomes in the BALANCE Trial. [PDF]

open access: yesKidney Int Rep
Wallace EL   +7 more
europepmc   +1 more source

Making Advanced Therapies Affordable and Accessible: Two Strategic Approaches

open access: yesDeveloping World Bioethics, EarlyView.
ABSTRACT This article explores two complementary strategies for addressing the affordability and access challenges facing advanced therapies. As high development costs and limited market access have led to the withdrawal of several therapies, the article examines how these barriers create ‘valleys of death’ that prevent innovation from reaching ...
Ubaka Ogbogu, Lauren Albrecht
wiley   +1 more source

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

open access: yesCardiac Failure Review, 2020
Zoltán Papp   +50 more
doaj   +1 more source

Reframing Justice in Healthcare AI: An Ubuntu‐Based Approach for Africa

open access: yesDeveloping World Bioethics, EarlyView.
ABSTRACT There is an ongoing debate on how to balance the benefits and risks of artificial intelligence (AI), especially in healthcare. In resource‐constrained settings, such as Africa, where access to quality care remains a challenge, AI has the potential to improve efficiency, accessibility, and patient outcomes.
Aloysius Ochasi   +3 more
wiley   +1 more source

Noninvasive cardiac index estimation under general anaesthesia: comparison between the VenArt® device and transthoracic echocardiography. [PDF]

open access: yesBJA Open
Paschoud C   +8 more
europepmc   +1 more source

Hybrid closed‐loop insulin delivery improves glycaemic control compared with sensor‐augmented pump therapy: A meta‐analysis of ‘free‐living’ randomised trials in type 1 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aim Although hybrid closed‐loop systems (HCLS) and sensor‐augmented pump (SAP) therapy are advanced diabetes management technologies for type 1 diabetes, their relative efficacy in optimising glycaemic control is not fully established. This meta‐analysis evaluated the impact of HCLS versus SAP therapy on glucose regulation across multiple ...
Amardeep S. Sidki   +3 more
wiley   +1 more source

A UK key opinion leader perspective: Navigating the immunological and logistical transformation brought by stem cell‐derived islets for the treatment of type 1 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims To explore UK key‐opinion leader perspectives on the future role of stem cell‐derived islets (sc‐islets) in islet transplantation for people with type 1 diabetes (T1D). Methods Four UK‐based key‐opinion leaders evaluated current limitations of donor islet transplantation and reviewed emerging evidence, clinical pathways and logistical ...
Thomas Strakosch, Shareen Forbes
wiley   +1 more source

Home - About - Disclaimer - Privacy